Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Monday, May 17, 2021

New drug approval: Dostarlimab - second line in advanced MSI endometrial cancer

xlomafota13 shared this article with you from Inoreader

Bull Cancer. 2021 May 13:S0007-4551(21)00177-6. doi: 10.1016/j.bulcan.2021.04.006. Online ahead of print.

NO ABSTRACT

PMID:33994164 | DOI:10.1016/j.bulcan.2021.04.006

View on the web

No comments:

Post a Comment